Literature DB >> 15598592

Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.

L D Locati, G Rinaldi, P Bossi, G P Dagrada, P Quattrone, G Cantú, L Licitra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15598592     DOI： 10.1016/j.oraloncology.2004.03.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  4 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.

Authors:  Aaron W Pederson; Joseph K Salama; Daniel J Haraf; Mary Ellen Witt; Kerstin M Stenson; Louis Portugal; Tanguy Seiwert; Victoria M Villaflor; Ezra E W Cohen; Everett E Vokes; Elizabeth A Blair
Journal:  Head Neck Oncol       Date:  2011-07-26

3.  Maintenance therapy with trastuzumab in her2 positive metastatic parotid ductal adenocarcinoma.

Authors:  Muhammad Shahid Iqbal; Ghazia Shaikh; Sanjoy Chatterjee; Helen Cocks; Josef Kovarik
Journal:  Case Rep Oncol Med       Date:  2014-07-17

4.  Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Authors:  Stephanie J Gros; Nina Kurschat; Astrid Drenckhan; Thorsten Dohrmann; Evelyn Forberich; Katharina Effenberger; Uta Reichelt; Robert M Hoffman; Klaus Pantel; Jussuf T Kaifi; Jakob R Izbicki
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.